How Vaccines Are Made and Manufactured: Viral Vector Platform

Source: Sartorius

Viral vector-based vaccines constitute a promising part of the biopharmaceutical pipeline, addressing many unmet indications. Some estimates show that half of the front runners of vaccine candidates for COVID-19 have used the viral vector platform. Moreover this is a complex platform with more than 40 vectors being used for both gene therapy and vaccines. Watch this video to learn how vaccines are manufactured using a viral-vector platform.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online